Vir biotech Inc Live Stock Price Today, Share Analysis and Chart

Name: Vir Biotechnology Inc: Is Infosys Ltd. worth buying?
Item: Vir Biotechnology Inc
Rating: 1.35265275
Author: Trendlyne DVM scores

Momentum Trap

about

Vir Biotechnology Inc is a clinical-stage biopharmaceutical company focused on powering the immune system by discovering and developing medicines for serious infectious diseases and cancer. The company uses its capabilities in antibody discovery and ...

9.48 -0.20 (-2.07%)

127.88% Gain from 52W Low

2.3M

XNAS Volume

XNAS 17 Mar, 2026 5:30 PM (EDT)

Low Financial Strength

11.1 / 100

Expensive Valuation

15.0 / 100

Technically Bullish

71.0 / 100

Momentum Trap These stocks have weak financials and expensive valuation. Buying interest may quickly dissipate. Investors should exercise caution View Similar Embed DVM

1Yr Price target upside is 119%

9 analysts

Vir biotech Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Vir biotech Inc Live Stock Price Today, Share Analysis and Chart

Vir Biotechnology Inc is a clinical-stage biopharmaceutical company focused on powering the immune system by discovering and developing medicines for serious infectious diseases and cancer. The company uses its capabilities in antibody discovery and ...

127.88% Gain from 52W Low

SWOT Analysis

Vir biotech Inc Live Price Chart